Search Results - "Carriero, M V"
-
1
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
Published in Cell death & disease (02-05-2013)“…Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent…”
Get full text
Journal Article -
2
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
Published in Journal of clinical oncology (01-05-1998)“…Since we have previously shown that the efflux rate of technetium 99m (99mTc) sestamibi, a transport substrate of P-glycoprotein (Pgp), is directly correlated…”
Get more information
Journal Article -
3
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma
Published in Cancer research (Chicago, Ill.) (15-03-2000)“…The regulatory mechanisms underlying the overexpression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in highly invasive breast…”
Get full text
Journal Article -
4
Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis
Published in British journal of dermatology (1951) (01-03-2003)“…Summary Background Recent evidence assigns the vitronectin receptors (VnRs) an important role in regulating tumour cell invasion and dissemination. In vivo and…”
Get full text
Journal Article -
5
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
Published in European Journal of Nuclear Medicine (01-02-1997)“…Technetium-99m sestamibi is a transport substrate recognised by the multidrug-resistant P-glycoprotein (Pgp). To test whether 99mTc-sestamibi efflux is…”
Get full text
Journal Article -
6
Fractional Retention of Technetium-99m-Sestamibi as an Index of P-Glycoprotein Expression in Untreated Breast Cancer Patients
Published in The Journal of nuclear medicine (1978) (01-09-1997)“…The multidrug-resistant phenotype is characterized by the reduced intracellular retention of several structurally and functionally unrelated cytotoxic…”
Get full text
Journal Article -
7
Vitronectin binding to urokinase receptor in human breast cancer
Published in Clinical cancer research (01-08-1997)“…Functional assembly of the plasminogen-dependent proteolytic system on the cell surface requires multiple interactions involving urokinase (uPA), urokinase…”
Get full text
Journal Article -
8
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography : comparison with urokinase levels
Published in Cancer research (Chicago, Ill.) (01-07-1993)“…We measured the tissue concentration of human urokinase receptor (uPAR) in 22 breast carcinomas and 9 benign breast lesions using in vitro quantitative…”
Get full text
Journal Article -
9
The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions
Published in The Journal of biological chemistry (06-12-2002)“…The urokinase-type plasminogen activator (uPA) is able to cleave its cell surface receptor (uPAR) anchored to the cell membrane through a…”
Get full text
Journal Article -
10
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies
Published in Cancer research (Chicago, Ill.) (15-10-1994)“…Current evidence regarding the regulation of urokinase-dependent extracellular proteolysis indicates that plasminogen activation is a surface-associated…”
Get full text
Journal Article -
11
Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by In Vitro Quantitative Autoradiography
Published in The Journal of nuclear medicine (1978) (01-04-1996)“…Folate binding protein (FBP) GP38 is a membrane-associated glycoprotein that mediates the intracellular transport of folates. The enhanced expression of FBP in…”
Get full text
Journal Article -
12
The soluble form of urokinase receptor promotes angiogenesis through its Ser88‐Arg‐Ser‐Arg‐Tyr92 chemotactic sequence
Published in Journal of thrombosis and haemostasis (01-12-2010)“…Background: The urokinase plasminogen activator receptor (u‐PAR) focuses the proteolytic activity of the urokinase plasminogen activator (u‐PA) on the…”
Get full text
Journal Article -
13
Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue
Published in Journal of clinical pathology (01-01-1984)“…An immunoperoxidase staining technique was used for detecting three major iron binding proteins (ferritin, transferrin and lactoferrin) in 40 breast carcinoma…”
Get full text
Journal Article -
14
Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats
Published in Circulation (New York, N.Y.) (19-06-2001)“…The mechanisms of increased neointimal hyperplasia after coronary interventions in diabetic patients are still unknown. Glucose and insulin effects on in vitro…”
Get full text
Journal Article -
15
Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence
Published in The EMBO journal (01-06-1999)“…Anchorage-independent myelomonocytic cells acquire adherence within minutes of differentiation stimuli, such as the proteolytically inactive N-terminal…”
Get full text
Journal Article -
16
In vitro receptor imaging for characterization of human solid tumors
Published in Nuclear medicine and biology (01-07-1994)“…Since many of the factors involved in tumor growth and progression act through a receptor-mediated mechanism, we applied in vitro receptor imaging techniques…”
Get more information
Journal Article -
17
Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study
Published in International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology (1991)“…The present study was performed to evaluate Ki-67 and B72.3 immunostaining in 20 selected cases of breast cancer. In particular, we have examined the…”
Get more information
Journal Article -
18
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells
Published in International journal of nanomedicine (01-01-2023)“…Currently, conventional treatments of hepatocellular carcinoma (HCC) are not selective enough for tumor tissue and lead to multidrug resistance and drug…”
Get full text
Journal Article -
19
TGF- beta 1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133 super(+) A549 cell fraction
Published in Cell death & disease (01-05-2013)“…Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent…”
Get full text
Journal Article -
20
TGF-[beta]1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
Published in Cell death & disease (01-05-2013)“…Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent…”
Get full text
Journal Article